Filing Details

Accession Number:
0001012975-18-000023
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-01-03 16:54:22
Reporting Period:
2017-12-29
Accepted Time:
2018-01-03 16:54:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1326190 Altimmune Inc. ALT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1201196 Mitchel Sayare C/O Altimmune, Inc.
19 Firstfield Road, Suite 200
Gaithersburg MD 20878
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Acquisiton 2017-12-29 5,100 $1.95 32,650 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Footnotes
  1. The price reflected is the weighted-average purchase price for shares purchased. The range of purchase prices for the transactions reported was $1.91 to $1.98 per share. The Reporting Person undertakes to provide, upon request by the Issuer, any security holder of the Issuer, or the SEC staff, full information regarding the number of shares purchased at each separate price.
  2. The shares of Common Stock are owned directly by the Mitchel Sayare 2010 Trust. The Reporting Person, as sole trustee of the Mitchel Sayare 2010 Trust, may be deemed to be the beneficial owner of the securities held by the Mitchel Sayare 2010 Trust. The Reporting Person disclaims beneficial ownership of the securities held by the Mitchel Sayare 2010 Trust except to the extent of his pecuniary interest therein.